The FDA Advisory Committee endorsed the Novavax Covid-19 Vaccine at their meeting June 7, 2022. It awaits the FDA Director’s decision and, if endorsed by the director, would next go to the CDC Advisory Committee for their evaluation, which looks like it might be scheduled later this month.
Go Retire Psychiatrist 